Effects of Cirrhosis on Short-term and Long-term Survival of Patients With Hepatitis B-related Hepatocellular Carcinoma

Clinical Gastroenterology and Hepatology

Volumn 14, Issue 6, 2016, Pages 887-895.e1

  Chen, Vincent L ^a   Le, An K ^a   Kim, Nathan G ^b   Kim, Lily H ^a,b   Nguyen, Nghia H ^c   Nguyen, Pauline P ^a   Zhao, Changqing ^a,d   Nguyen, Mindie H ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Carcinogenesis; Liver Cancer; Mortality; Progression

Indexed keywords

SORAFENIB;

ABDOMINAL PAIN; ADULT; ARTICLE; CHEMOEMBOLIZATION; COHORT ANALYSIS; DECOMPENSATED LIVER CIRRHOSIS; FEMALE; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PARTIAL HEPATECTOMY; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; SHORT TERM SURVIVAL; SURVIVAL TIME; TUMOR VOLUME; WEIGHT REDUCTION; AGED; CARCINOMA, HEPATOCELLULAR; CHRONIC HEPATITIS B; COMPLICATION; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL ANALYSIS;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84964684035     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2015.12.044     Document Type: Article

References (28)

1. Global cancer facts & figures 2011, American Cancer Society, Atlanta. 2nd ed.
2. Cancer incidence in five continents. Vol IX 2007, IARC Scientific Publications, Lyon.
3. Beasley R.P., Lin C.-C., Hwang L.-Y., et al. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22 707 men in Taiwan. Lancet 1981, 318:1129-1133.
4. Poon R.T.-P., Fan S.-T., Lo C.-M., et al. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. J Clin Oncol 2000, 18:1094-1101.
5. Kim J.M., Kwon C.H.D., Joh J.-W., et al. Differences between hepatocellular carcinoma and hepatitis B virus infection in patients with and without cirrhosis. Ann Surg Oncol 2014, 21:458-465.
6. Bruix J., Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236.
7. Bruix J., Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011, 53:1020-1022.
8. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. Eur J Cancer 2012, 48:599.
9. Kudo M., Izumi N., Kokudo N., et al. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis 2010, 29:339-364.
10. Zhang B.-H., Yang B.-H., Tang Z.-Y. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004, 130:417-422.
11. Wu C.-Y., Hsu Y.-C., Ho H.J., et al. Association between ultrasonography screening and mortality in patients with hepatocellular carcinoma: a nationwide cohort study. Gut 2015, 65:693-701.
12. Bolondi L., Sofia S., Siringo S., et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 2001, 48:251-259.
13. Davila J.A., Morgan R.O., Richardson P.A., et al. Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology 2010, 52:132-141.
14. Wong C.R., Garcia R.T., Trinh H.N., et al. Adherence to screening for hepatocellular carcinoma among patients with cirrhosis or chronic hepatitis B in a community setting. Dig Dis Sci 2009, 54:2712-2721.
15. Sarkar M., Stewart S., Yu A., et al. Hepatocellular carcinoma screening practices and impact on survival among hepatitis B-infected Asian Americans. J Viral Hepat 2012, 19:594-600.
16. Available at: . 2015. Accessed July 13, 2015. http://www.cdc.gov/nchs/ndi.htm.
17. Imamura H., Matsuyama Y., Tanaka E., et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 2003, 32:200-207.
18. Kamatha P.S., Wiesnera R.H., Malinchocb M., et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001, 33:464-470.
19. Benvegnu L., Noventa F., Bernardinello E., et al. Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development. Gut 2001, 48:110-115.
20. Khalili M., Guy J., Yu A., et al. Hepatitis B and hepatocellular carcinoma screening among Asian Americans: survey of safety net healthcare providers. Dig Dis Sci 2011, 56:1516-1523.
21. Zhao C., Jin M., Le R.H., et al. Regional and etiological differences in the adherence to hepatocellular carcinoma (HCC) surveillance among patients of chronic hepatitis B (CHB) and cirrhosis of all etiologies: a meta-analysis of 15,429 patients from 14 individual studies. Hepatology 2015, 62(S).
22. Jin M.Q., Le R.H., Jin M., et al. Proportions of hepatocellular carcinoma (HCC) diagnosed by screening, surveillance, or without symptoms is dismally low across different world regions and underlying liver diseases. Hepatology 2015, 62(S).
23. Altekruse S.F., McGlynn K.A., Reichman M.E. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009, 27:1485-1491.
24. Altekruse S.F., McGlynn K.A., Dickie L.A., et al. Hepatocellular carcinoma confirmation, treatment, and survival in Surveillance, Epidemiology, and End Results Registries, 1992-2008. Hepatology 2012, 55:476-482.
25. Devaki P., Jencks D., Yee B.E., et al. Systematic review with meta-analysis: sustained virologic response in hepatitis C genotype 5 patients treated with pegylated interferon and ribavirin-a meta-analysis of 423 patients from 10 studies. Hepatol Int 2015, 9:431-437.
26. Robbins A.S., Cox D.D., Johnson L.B., et al. Persistent disparities in liver transplantation for patients with hepatocellular carcinoma in the United States, 1998 through 2007. Cancer 2011, 117:4531-4539.
27. Artinyan A., Mailey B., Sanchez-Luege N., et al. Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States. Cancer 2010, 116:1367-1377.
28. Wong R.J., Devaki P., Nguyen L., et al. Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: results from the surveillance, epidemiology, and end results registry. Liver Transpl 2014, 20:528-535.